| 영문 | vasopressin | 한글 | 바소프레신 |
|---|---|---|---|
| 설명 | 시상하부 신경핵의 신경세포에서 만들어지며, 뇌하수체 후엽에 저장되는 2종의 호르몬 중의 하나. 항이뇨호르몬(antidiuretic hormone, ADH)이라고도 한다. 다른 1종은 옥시토신이다. 모세혈관과 세동맥을 구성하는 평활근 조직의 수축을 자극하여 혈압을 상승시키는 작용이 있다. 창자근육의 수축을 자극하고, 꿈틀운동을 증강시키며, 자궁에도 영향을 준다. 또한 요세관 원위부의 상피세포에 특수한 작용을 일으켜, 고형물의 흡수와는 관계없이 수분의 재흡수를 항진시켜 오줌을 농축시킨다. 바소프레신은 합성에 의해서도 만들어지고, 또한 가축의 하수체 후엽으로부터도 얻어지며, 항이뇨제로서 주사액으로도 사용된다. 고리 모양으로 폴리펩티드결합을 이룬다. 포유류에서 광범위하게 볼 수 있는 것으로 콩팥에서 수분의 재흡수를 촉진하는 물질로 작용한다. 모세혈관을 수축시켜 혈압을 높이는 작용이 있으므로 저혈압 치료에 이용된다. |
||
| 영문 | iron deficiency anemia | 한글 | 철결핍빈혈 |
|---|---|---|---|
| 설명 | 적혈구의 기능은 산소를 운반하는데 있다. 적혈구 속에 산소와 결합을 하여 산소를 운반하는 혈색소라는 물질이 있다. 철은 이 혈색소의 중요한 부분을 이루는 것으로 철이 없으면 혈색소가 만들어질 수가 없다. 혈색소가 없으면 역시 적혈구도 만들어지지 않으므로 체내에 철이 부족하면 빈혈이 생긴다. 이 철결핍성 빈혈은 빈혈의 원인 중에서 가장 흔한 것이다(약 25%를 차지한다). 철저장량의 저하-결핍, 혈청철농도의 저하, 트란스페린량 상승, 트란스페린포화도의 저하, 혈색소농도 또는 헤마토크리트의 저하, 저색소성대적혈구를 특징으로 하는 빈혈로서, 생체 내에서 철이 장기에 걸쳐 결핍되며 그 때문에 혈색소 생산 감소에 의해 일어난다. 창자에서의 철흡수량 부족, 철의 수요 증대(유아기, 사춘기, 임신), 철소실과잉(출혈)에 의해 일어나며, 특히 사춘기에서 폐경기까지의 여성에게 많다. 증상으로서는 얼굴창백, 피로감, 피부창백, 손톱 변화(스푼 모양) 등을 나타낸다. 구강 영역에서는 혀의 접촉통, 발적, 건조감, 삼킴곤란을 수반하면 플러머-빈슨(Plummer-Vinson)증후군이라고 한다. 혈액 소견은 혈청철은 저하하며, 철결합능력의 상승, 저색소성 작은적혈구성을 나타낸다. |
||
| AVP | abnormal vasopressin; actinomycin-vincristine-Platinol; ambulatory venous pressure; antiviral protei... |
|---|---|
| DDAVP, dDAVP | 1-deamino-8-D-arginine vasopressin; 1-deamino-8-N-arginine vasopressin |
| MD | Doctor of Medicine [Lat. Medicinae Doctor]; magnesium deficiency; main duct; maintenance dose; major... |
| IGD | idiopathic growth hormone deficiency; interglobal distance; isolated gonadotropin deficiency |
| MCD | magnetic circular dichroism; mast-cell degranulation; mean cell diameter; mean of consecutive differ... |
| DDAVP | 1,desamino-8-D-arginine vasopressin |
|---|---|
| AVP | 3)H]arginine vasopressin |
| 3H-AVP | 3H-arginine-vasopressin |
| AVP | 8-Arg]-vasopressin |
| AVP | 8-Arginine vasopressin |
| arginine vasopressin | [8-arginine]vasopressin; [Arg8]vasopressin;vasopressin containing an arginyl residue in position 8 (as in chickens and most mammals, including man); porcine vasopressin has a lysyl residue at position 8. All are vasopressors. Synonym: argipressin. (05 Mar 2000) |
|---|---|
| vasopressin | <protein> A peptide hormone released from the posterior pituitary lobe but synthesised in the hypothalamus. There are 2 forms, differing only in the amino acid at position 8: arginine vasopressin is widespread, while lysine vasopressin is found in pigs. Has antidiuretic and vasopressor actions. Used in the treatment of diabetes insipidus. (18 Nov 1997) |
| vasopressin-converting aminopeptidase | <enzyme> Activity found in brain which converts vasopressin into centrally active metabolites Registry number: EC 3.4.11.- Synonym: vp-c aminopeptidase (26 Jun 1999) |
| vasopressin level | This test measures the amount of ADH in the serum. It is used to detect disorders that may affect the level of ADH in the serum. Normal values are: 0 to 4.7 pg/ml. Elevated ADH levels can indicate a CNS infection, fluid imbalance, CNS tumour, SIADH or acute porphyria. Low levels can indicate: diabetes insipidus or damage to the pituitary gland. (27 Sep 1997) |
| vasopressin-resistant diabetes | Diabetes insipidus due to inability of the kidney tubules to respond to antidiuretic hormone; X-linked inheritance, with full expression in males and partial defect in heterozygous females. Synonym: vasopressin-resistant diabetes. (05 Mar 2000) |
| receptors, vasopressin | Specific molecular sites or structures on or in cells that vasopressins react or to which they bind in order to modify the function of the cells. Two types of vasopressin receptor exist, the v1 receptor and the v2 receptor. The v1 receptor can be subdivided into v1a and v1b (formerly v3) receptors. (12 Dec 1998) |
| unit of vasopressin | The pressor activity of 0.5 mg of the USP Posterior-pituitary Reference Standard; 1 mg of synthetic vasopressin corresponds to 600 IU. (05 Mar 2000) |
| 8-lysine vasopressin | <chemical> 8-lysyl vasopressin. The porcine antidiuretic hormone most frequently used clinically. A cyclic nonapeptide with lysine in position 8 of the chain; it is used to treat diabetes insipidus and as haemostatic because of its vasoconstrictor action. Pharmacological action: haemostatics, renal agents, vasoconstrictor agents. Chemical name: Vasopressin, 8-L-lysine- (12 Dec 1998) |
| abdominal muscle deficiency syndrome | <syndrome> Congenital absence (partial or complete) of abdominal muscles, in which the outline of the intestines is visible through the protruding abdominal wall; in males, genitourinary anomalies (urinary tract dilation and cryptorchidism) are also found; genetics unclear. (05 Mar 2000) |
| adult lactase deficiency | Onset of lactase deficiency, with resulting milk intolerance and malabsorption, in adulthood. Inherited forms may not be manifested until adulthood; any process that damages the intestinal lining cells can cause lactase deficiency in adults. (05 Mar 2000) |
| alpha-1 antitrypsin deficiency | <chest medicine> Deficiency of the protease inhibitor alpha-1 antitrypsin, leads primarily to degradation of elastin of the alveolar walls, as well as other structural proteins of a variety of tissues. The lack of this protein leads to damage of various organs, but mainly to the lung and liver. symptoms may become apparent at a very early age or in adulthood, manifesting either as shortness of breath or liver related symptoms (jaundice, fatigue, fluid in the abdomen, mental changes, or gastrointestinal bleeding). There are several options for treatment of the lung disease, including replacement of the missing protein. Treatment of the liver disease is a well-timed liver transplant (12 Dec 1998) |
| alpha-1-proteinase deficiency | Absence of a serum proteinase inhibitor that may cause nodular non-suppurative panniculitis. (05 Mar 2000) |
| alpha-antitrypsin deficiency | <enzyme> A specific enzyme (alpha 1 antitrypsinase) that when absent genetically can result in panacinar emphysema (lung disease) and liver disease. There is no specific treatment for this condition other than supportive care for the liver and lung complications. Medications such as alpha-1proteinase inhibitor is given regularly to these patients. Incidence: approximately 1 in 10,000. (02 Jan 1998) |
| anaemia, iron deficiency | Deficiency of iron results in anaemia because iron is necessary to make haemoglobin, the key molecule in red blood cells responsible for the transport of oxygen. In iron deficiency anaemia, the red cells are unusally small (microcytic) and pale (hypochromic). Characteristic features of iron deficiency anaemia in children include failure to thrive (grow) and increased infections. The treatment of iron deficiency anaemia, whether it be in children or adults, is with iron and iron-containing foods. Food sources of iron include meat, poultry, eggs, vegetables and cereals (especially those fortified with iron). According to the National Academy of Sciences, the Recommended Dietary Allowances of iron are 15 milligrams per day for women and 10 milligrams per day for men. Anaemia characterised by low or absent iron stores, low serum iron concentration, elevated free erythrocyte porphorin, low transferrin saturation, elevated transferrin, low serum ferritin, low haemoglobin concentration or haematocrit, and hypochromic microcytic red blood cells. Symptoms may include pallor, angular stomatitis and other oral lesions, gastrointestinal complaints, retinal haemorrhages and exudates, and thinning and brittleness of the nails. Among the causes of iron-deficiency anaemia are inadequate iron intake, impaired iron absorption, increased blood loss and increased requirements such as infancy, pregnancy, and lactation. (12 Dec 1998) |
| antibody deficiency disease | <syndrome> Any of a group of disorders associated with a defective antibody production due to defects in the B-type lymphocyte system or in T-type lymphocytes; chief manifestation is an increased susceptibility to infection by various microorganisms. See: agammaglobulinaemia, hypogammaglobulinaemia, immunodeficiency. Synonym: antibody deficiency disease. (05 Mar 2000) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|